RALOXIFENE IS A TISSUE-SELECTIVE AGONIST-ANTAGONIST THAT FUNCTIONS THROUGH THE ESTROGEN-RECEPTOR

被引：72

作者：

FUCHSYOUNG, R

GLASEBROOK, AL

SHORT, LL

DRAPER, MW

RIPPY, MK

COLE, HW

MAGEE, DE

TERMINE, JD

BRYANT, HU

机构：

[1] Skeletal Disease Research Endocrine Division, Lilly Research Laboratories Eli Lilly and Co., Indianapolis, Indiana

来源：

STEROID RECEPTORS AND ANTIHORMONES | 1995年 / 761卷

关键词：

D O I：

10.1111/j.1749-6632.1995.tb31392.x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：355 / 360

页数：6

共 8 条

[1] RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS [J].

BLACK, LJ ;

SATO, M ;

ROWLEY, ER ;

MAGEE, DE ;

BEKELE, A ;

WILLIAMS, DC ;

CULLINAN, GJ ;

BENDELE, R ;

KAUFFMAN, RF ;

BENSCH, WR ;

FROLIK, CA ;

TERMINE, JD ;

BRYANT, HU .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :63-69

[2] EFFECTS OF A NEW ANTI-ESTROGEN, KEOXIFENE (LY156758), ON GROWTH OF CARCINOGEN-INDUCED MAMMARY-TUMORS AND ON LH AND PROLACTIN LEVELS [J].

CLEMENS, JA ;

BENNETT, DR ;

BLACK, LJ ;

JONES, CD .

LIFE SCIENCES, 1983, 32 (25) :2869-2875

[3]

DRAPER M, 1994, CALCIFIED TISSUE INT, V4, P339

[4]

DRAPER MW, 1993, 4TH P INT S OST, P119

[5]

GLASEBROOK AL, 1993, J BONE MINER RES, V8, pS268

[6]

THOMPSON EW, 1988, CANCER RES, V48, P6764

[7]

YANG N, 1994, UNPUB TGF BETA 3 TAR

[8]

YANG N, 1994, UNPUB ESTROGEN RECEP

← 1 →